InsiderTrades

Form 4 for BIVI BIOVIE INC.

Accepted 2024-07-12 00:00:00 ET · period of report 2023-02-16 · accession 0001520138-24-000240 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-07-12 2023-02-16+ BIVI KIM JOANNE WENDY CFO F - Tax $1.08 -23.2K 39.2K -37% -$25.1K
D 2024-07-12 2024-06-24 BIVI KIM JOANNE WENDY CFO A - Grant $0.00 +73.0K 112.2K +186% $0
D 2024-07-12 2024-06-24 BIVI KIM JOANNE WENDY CFO A - Grant $0.00 +99.0K 99.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-16 F D 2,476 $5.51 41,672 D — —
2 Common Common Stock 2024-06-24 F D 18,250 $0.47 93,940 D — — (F1) The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024.
3 Common Common Stock 2024-06-24 A A 73,000 $0.00 112,196 D — — (F1) The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on June 10, 2024, which grant became effective on June 24, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vested in full on June, 24, 2024.
4 Common Common Stock 2024-02-15 F D 2,476 $1.18 39,196 D — —
5 Derivative Stock Option (right to buy) 2024-06-24 A A 99,000 $0.00 99,000 D $0.47 · — to 2034-06-24 99,000 Common Stock (F2) The options vest in three equal annual installments beginning on June 24, 2024.